IL36A and neoplasm: This effect was further verified by the time‐ or dose‐ dependent proliferation and formation of vessel‐like tubes of HUVECs in vitro treated with rhIL‐36α, indicating that IL‐36α regulated tumor angiogenesis by targeting VEGFA.